| 書目名稱 | Combination Treatment in Autoimmune Diseases | | 編輯 | W. B. Harrison,B. A. C. Dijkmans | | 視頻video | http://file.papertrans.cn/230/229863/229863.mp4 | | 圖書封面 |  | | 描述 | W. B. Harrison, B. A. C. Dijkmans During the last decade intervention has been instituted for all kinds of disease- even in a premorbid state, as early as possible, to control the activity of the disease, to avoid further damage and to maintain quality of life. Apart from the principle ‘Treat now, not later", emphasis is laid on aggressive initial therapy. These adagia have influenced in recent times all fields of medicine, from oncology to infectious diseases and also - the topic of the present edition - the "autoimmune diseases". As an example of the latter, rheumatoid arthritis (RA) demonstrates how the attitude of physicians has been changed. From an expectant point of view in the eighties (primum nil nocere) the attitude has been changed, as we approached and entered the new millennium, to initial ag- gressive therapy especially in patients with a poor prognosis. Despite the advance of instituting monotherapy with a single optimised disease-modifying anti-rheumatic drug (DMARD) - with methotrexate as prototype agent in RA - adequate disease re- mission is not often achieved, and adverse events may well prevent the use of higher dosages of the single agent in question. Therefor | | 出版日期 | Book 2002 | | 關(guān)鍵詞 | Autoimmune diseases; Sj?gren‘s syndrome; autoimmune disease; cell; diseases; erythematosus; immunotherapy; | | 版次 | 1 | | doi | https://doi.org/10.1007/978-3-662-04759-0 | | isbn_softcover | 978-3-642-07704-3 | | isbn_ebook | 978-3-662-04759-0 | | copyright | Springer-Verlag Berlin Heidelberg 2002 |
The information of publication is updating
|
|
|Archiver|手機(jī)版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-13 22:00
發(fā)表于 2025-3-21 19:43:44
